Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MELANOMA - SECONDARY , . Treffer: 55

2018

Giuffrida, R; Kashofer, K; Dika, E; Patrizi, A; Baraldi, C; Di Meo, N; Zalaudek, I Fast growing melanoma following treatment with vismodegib for locally advanced basal cell carcinomas: report of two cases.
Eur J Cancer. 2018; 91(2):177-179 Doi: 10.1016/j.ejca.2017.11.031 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Menzer, C; Beedgen, B; Rom, J; Duffert, CM; Volckmar, AL; Sedlaczek, O; Richtig, E; Enk, A; Jäger, D; Hassel, JC Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy.
Eur J Cancer. 2018; 104(2):239-242 Doi: 10.1016/j.ejca.2018.09.008 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2017

Richtig, G; Richtig, E; Kashofer, K; Koch, L; Winter, G; Hoefler, G; Pichler, M; Ehall, B; Grübler, MR; Heinemann, A; Aigelsreiter, A Testing and clinical implications for non-V600 BRAF mutations in metastatic NRASmt melanoma.
Br J Dermatol. 2017; 177(3):860-861 Doi: 10.1111/bjd.15222
Web of Science PubMed FullText FullText_MUG

 

2016

Garg, K; Maurer, M; Griss, J; Brüggen, MC; Wolf, IH; Wagner, C; Willi, N; Mertz, KD; Wagner, SN Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Hum Pathol. 2016; 54(6):157-164 Doi: 10.1016/j.humpath.2016.03.022
Web of Science PubMed FullText FullText_MUG

 

Lazova, R; Seeley, EH; Kutzner, H; Scolyer, RA; Scott, G; Cerroni, L; Fried, I; Kozovska, ME; Rosenberg, AS; Prieto, VG; Shehata, BM; Durham, MM; Henry, G; Rodriguez-Peralto, JL; Riveiro-Falkenbach, E; Schaefer, JT; Danialan, R; Fraitag, S; Vollenweider-Roten, S; Sepehr, A; Sangueza, M; Hijazi, N; Corredoira, Y; Kowal, R; Harris, OM; Bravo, F; Boyd, AS; Gueorguieva, R; Caprioli, RM Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms.
J Am Acad Dermatol. 2016; 75(6):1176-1186 Doi: 10.1016/j.jaad.2016.07.007 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lee, SB; Weide, B; Ugurel, S; Mössner, R; Enk, A; Hassel, JC Vemurafenib-induced granuloma annulare.
J Dtsch Dermatol Ges. 2016; 14(3):305-308 Doi: 10.1111/ddg.12777 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Ribero, S; Pampena, R; Bataille, V; Moscarella, E; Thomas, L; Quaglino, P; Potenza, C; Van Akkooi, ACJ; Testori, A; Nathan, P; Puig, S; Zalaudek, I; Argenziano, G; Longo, C Unknown Primary Melanoma: Worldwide Survey on Clinical Management.
Dermatology. 2016; 232(6):704-707 Doi: 10.1159/000453592 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Gorensek, K; Arzberger, E; Hofmann-Wellenhof, R [Pigmented macule on the neck, red nodules on the trunk. Diagnosis: neck left: Melanoma. Pectoral right: Breast cancer].
Hautarzt. 2015; 66(12):964-966 Doi: 10.1007/s00105-015-3683-0 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2014

Keeling, IM; Knez, I; Richtig, E; Zweiker, R; Aigelsreiter, A; Dacar, D Cardiac surgery for metastatic melanoma.
Wien Klin Wochenschr. 2014; 126(9-10):261-262 Doi: 10.1007/s00508-014-0518-4 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Niederkorn, A; Wackernagel, W; Artl, M; Schwantzer, G; Aigner, B; Richtig, E Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
Acta Ophthalmol. 2014; 92(8):e696-e697 Doi: 10.1111/aos.12432 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weide, B; Eigentler, TK; Pflugfelder, A; Zelba, H; Martens, A; Pawelec, G; Giovannoni, L; Ruffini, PA; Elia, G; Neri, D; Gutzmer, R; Becker, JC; Garbe, C Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.
Cancer Immunol Res. 2014; 2(7):668-678 Doi: 10.1158/2326-6066.CIR-13-0206 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Aigner, B; Plötz, SG; Schaller, G Triple-negative breast cancer possibly transforming into malignant melanoma due to targeted therapy? A case report and review of literature.
Wien Med Wochenschr. 2013; 163(21-22): 495-498. Doi: 10.1007/s10354-013-0242-0 (- Case Report)
PubMed FullText FullText_MUG

 

Aigner, B; Richtig, E; Becker, JC; Lingitz, H; Niederkorn, RMA; Ugurel, S; Partial Response of Metastatic Mucosal Melanoma After Palliative Chemotherapy With Trofosfamide: A Case Report.
J Clin Oncol. 2013; 31(2):e31-e32 Doi: 10.1200/JCO.2012.44.2053 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Degen, A; Weichenthal, M; Ugurel, S; Trefzer, U; Kilian, K; Garbe, C; Egberts, F; Poppe, LM; Hauschild, A; Gutzmer, R Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial).
J Dtsch Dermatol Ges. 2013; 11(9):846-853 Doi: 10.1111/ddg.12100
Web of Science PubMed FullText FullText_MUG

 

Partl, R; Richtig, E; Avian, A; Berghold, A; Kapp, KS Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Int J Radiat Oncol Biol Phys. 2013; 85(3):662-666 Doi: 10.1016/j.ijrobp.2012.06.009
Web of Science PubMed FullText FullText_MUG

 

Richtig, E; Schrama, D; Ugurel, S; Fried, I; Niederkorn, A; Massone, C; Becker, JC BRAF mutation analysis of only one single metastatic lesion can restrict the treatment of melanoma - a case report.
Br J Dermatol. 2013; 168(2):428-430 Doi: 10.1111/j.1365-2133.2012.11121.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2012

Gschaider, M; Neumann, F; Peters, B; Lenz, F; Cibena, M; Goiser, M; Wolf, I; Wenzel, J; Mauch, C; Schreiner, W; Wagner, SN An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma.
PLoS One. 2012; 7(11):e49865-e49865 Doi: 10.1371/journal.pone.0049865 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Liu, SJ; Tetzlaff, MT; Liu, AH; Liegl-Atzwanger, B; Guo, J; Xu, XW; Loss of microRNA-205 expression is associated with melanoma progression.
Lab Invest. 2012; 92(7):1084-1096 Doi: 10.1038/labinvest.2012.62 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Ugurel, S; Becker, JC [Treatment of advanced metastatic melanoma].
Hautarzt. 2011; 62(6):423-429 Doi: 10.1007/s00105-010-2041-5
Web of Science PubMed FullText FullText_MUG

 

Vergier, B; Prochazkova-Carlotti, M; de la Fouchardière, A; Cerroni, L; Massi, D; De Giorgi, V; Bailly, C; Wesselmann, U; Karlseladze, A; Avril, MF; Jouary, T; Merlio, JP Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Mod Pathol. 2011; 24(5):613-623 Doi: 10.1038/modpathol.2010.228 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Damm, S; Koefinger, P; Stefan, M; Wels, C; Mehes, G; Richtig, E; Kerl, H; Otte, M; Schaider, H HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-kappa B, Egr-1, and C/EBP-beta.
J Invest Dermatol. 2010; 130(7): 1893-1903. Doi: 10.1038/jid.2010.45 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Schintler, MV; Arbab, E; Laback, C; Prandl, E; Kash, N; Scharnagl, E; Richtig, E Neurofibroma of the tibial nerve mimicking popliteal lymph node metastasis in malignant melanoma.
Dermatol Surg. 2010; 36(4): 555-557. Doi: 10.1111/j.1524-4725.2010.01500.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Van Raamsdonk, CD; Griewank, KG; Crosby, MB; Garrido, MC; Vemula, S; Wiesner, T; Obenauf, AC; Wackernagel, W; Green, G; Bouvier, N; Sozen, MM; Baimukanova, G; Roy, R; Heguy, A; Dolgalev, I; Khanin, R; Busam, K; Speicher, MR; O'Brien, J; Bastian, BC Mutations in GNA11 in Uveal Melanoma.
N ENGL J MED. 2010; 363(23): 2191-2199. Doi: 10.1056/NEJMoa1000584 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2009

Beer, M; Winkelmann, V; Becker, JC; Terheyden, P; Stenzel, M; Brocker, EB; Hahn, D; Kostler, H Spectroscopic imaging of the human liver using 3D CSI: optimization and application in patients with metastatic uvea melanoma
Rofo. 2009; 181(1):60-66 Doi: 10.1055/s-2008-1027887 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hofmann, UB; Kauczok-Vetter, CS; Houben, R; Becker, JC Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
Clin Cancer Res. 2009; 15(1):324-329 Doi: 10.1158/1078-0432.CCR-08-2243 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Straten, PT; Becker, JC Adoptive cell transfer in the treatment of metastatic melanoma.
J Invest Dermatol. 2009; 129(12):2743-2745 Doi: 10.1038/jid.2009.204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Gattenlohner, S; Brocker, E; Muller-Hermelink, H Malignant melanoma with metastatic rhabdomyosarcomatoid transdifferentiation.
N Engl J Med. 2008; 358(6):649-650 Doi: 10.1056/NEJMc0707079 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hauschild, A; Trefzer, U; Garbe, C; Kaehler, KC; Ugurel, S; Kiecker, F; Eigentler, T; Krissel, H; Schott, A; Schadendorf, D Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.
Melanoma Res. 2008; 18(4):274-278 Doi: 10.1097/CMR.0b013e328307c248
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Spieth, K; Kaufmann, R; Dummer, R; Garbe, C; Becker, JC; Hauschild, A; Tilgen, W; Ugurel, S; Beyeler, M; Bröcker, EB; Kaehler, KC; Pföhler, C; Gille, J; Leiter, U; Schadendorf, D Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Ann Oncol. 2008; 19(4):801-806 Doi: 10.1093/annonc/mdm565 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Otto, K; Starz, H; Becker, JC; Schrama, D Overexpression of matrix metalloproteinases, chemokines, and chemokine receptors relevant for metastasis in experimental models not an indication of lymph node metastases in human melanoma.
Arch Dermatol. 2007; 143(7):947-948 Doi: 10.1001/archderm.143.7.947 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Terheyden, P; Hofmann, MA; Weininger, M; Brocker, EB; Becker, JC Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.
J Cancer Res Clin Oncol. 2007; 133(11):897-901 Doi: 10.1007/s00432-007-0251-8 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Thirumaran, RK; Bloethner, S; Gast, A; Sucker, A; Mueller-Berghaus, J; Rittgen, W; Hemminki, K; Becker, JC; Kumar, R; Schadendorf, D B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact Prognosis
PLOS ONE. 2007; 2(2): Doi: 10.1371/journal.pone.0000236 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2006

Hoek, KS; Schlegel, NC; Brafford, P; Sucker, A; Ugurel, S; Kumar, R; Weber, BL; Nathanson, KL; Phillips, DJ; Herlyn, M; Schadendorf, D; Dummer, R Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.
Pigment Cell Res. 2006; 19(4):290-302 Doi: 10.1111/j.1600-0749.2006.00322.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schledzewski, K; Falkowski, M; Moldenhauer, G; Metharom, P; Kzhyshkowska, J; Ganss, R; Demory, A; Falkowska-Hansen, B; Kurzen, H; Ugurel, S; Geginat, G; Arnold, B; Goerdt, S Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis.
J Pathol. 2006; 209(1):67-77 Doi: 10.1002/path.1942
Web of Science PubMed FullText FullText_MUG

 

Thoelke, A; Schmid, HP; Figl, R; Schadendorf, D; Ugurel, S Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma.
Eur J Dermatol. 2006; 16(4):428-430 (- Case Report) [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

Utikal, J; Thoelke, A; Becker, JC; Figl, R; Goerdt, S; Schadendorf, D; Ugurel, S Local cutaneous argyria mimicking melanoma metastases in a patient with disseminated melanoma.
J Am Acad Dermatol. 2006; 55(5 Suppl):S92-S94 Doi: 10.1016/j.jaad.2005.10.062 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Utikal, J; Zimpfer, A; Thoelke, A; Figl, R; Hildenbrand, R; Kettelhack, C; Goerdt, S; Schadendorf, D; Ugurel, S Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod.
Br J Dermatol. 2006; 155(2):488-491 Doi: 10.1111/j.1365-2133.2006.07333.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Wobser, M; Siedel, C; Schrama, D; Brocker, EB; Becker, JC; Vetter-Kauczok, CS Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Arch Dermatol Res. 2006; 297(8):352-357 Doi: 10.1007/s00403-005-0633-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Andersen, MH; Fensterle, J; Ugurel, S; Reker, S; Houben, R; Guldberg, P; Berger, TG; Schadendorf, D; Trefzer, U; Brocker, EB; Straten, PT; Rapp, UR; Becker, JC Immunogenicity of constitutively active (V599E)BRaf
CANCER RES. 2004; 64(15): 5456-5460. Doi: 10.1158/0008-5472.CAN-04-0937 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fink, W; Zimpfer-Rechner, C; Thoelke, A; Figl, R; Kaatz, M; Ugurel, S; Schadendorf, D Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma.
Onkologie. 2004; 27(6):540-544 Doi: 10.1159/000081335
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Uhlig, D; Pföhler, C; Tilgen, W; Schadendorf, D; Reinhold, U Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.
Cancer Immunol Immunother. 2004; 53(6):551-559 Doi: 10.1007/s00262-003-0489-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Dresel, S; Grammerstorff, J; Schwenzer, K; Brinkbäumer, K; Schmid, R; Pfluger, T; Hahn, K 18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
Eur J Nucl Med Mol Imaging. 2003; 30(7):995-1003 Doi: 10.1007/s00259-003-1181-6
Web of Science PubMed FullText FullText_MUG

 

Fink, W; Zimpfer, A; Ugurel, S Mucosal metastases in malignant melanoma.
Onkologie. 2003; 26(3):249-251 Doi: 10.1159/000071620 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Richtig, E; Hoff, M; Rehak, P; Kapp, K; Hofmann-Wellenhof, R; Zalaudek, I; Poschauko, J; Uggowitzer, M; Kohek, P; Smolle, J Efficacy of superficial and deep regional hyperthermia combined with systemic chemotherapy and radiotherapy in metastatic melanoma.
J Dtsch Dermatol Ges. 2003; 1(8):635-642 Doi: 10.1046/j.1610-0387.2003.03719.x
PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Tilgen, W; Reinhold, U Chemosensitivity testing in malignant melanoma.
Recent Results Cancer Res. 2003; 161(8):81-92 Doi: 10.1007/978-3-642-19022-3_8
PubMed FullText FullText_MUG

 

Wolf, IH; Smolle, J; Binder, B; Cerroni, L; Richtig, E; Kerl, H Topical imiquimod in the treatment of metastatic melanoma to skin.
Arch Dermatol. 2003; 139(3):273-276 Doi: 10.1001/archderm.139.3.273 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Becker, JC; Terheyden, P; Kampgen, E; Wagner, S; Neumann, C; Schadendorf, D; Steinmann, A; Wittenberg, G; Lieb, W; Brocker, EB Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
Br J Cancer. 2002; 87(8):840-845 Doi: 10.1038/sj.bjc.6600521 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Schrama, D; Fuchs, E; Brocker, EB; Straten, PT; Becker, JC Identical T-cell receptor transcripts in multiple melanoma metastases.
Cancer Res. 2002; 62(20):5664-5667 [OPEN ACCESS]
Web of Science PubMed FullText

 

Ugurel, S; Wagner, A; Pföhler, C; Tilgen, W; Reinhold, U Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread.
Br J Dermatol. 2002; 147(3):621-624 Doi: 10.1046/j.1365-2133.2002.488811.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Vetter, CS; Groh, V; Straten, PT; Spies, T; Brocker, EB; Becker, JC Expression of stress-induced MHC class I related chain molecules on human melanoma.
J Invest Dermatol. 2002; 118(4):600-605 Doi: 10.1046/j.1523-1747.2002.01700.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum